Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience
Open Access
- 9 September 2004
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (10) , 1587-1590
- https://doi.org/10.1038/sj.leu.2403480
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Acute promyelocytic leukaemia in childrenBest Practice & Research Clinical Haematology, 2003
- Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: A single center experienceAmerican Journal of Hematology, 2002
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in childrenAnnals of Hematology, 2001
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999
- Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia PatientsBlood, 1999
- All-Trans-Retinoic Acid (ATRA): Pediatric Acute Promyelocytic LeukemiaPediatric Hematology and Oncology, 1998